Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
fNgdUV6RNLsgsk4X
